封面
市场调查报告书
商品编码
1980776

全球影像导引治疗系统市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Image-guided Therapy Systems Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

影像导引治疗系统市场预计将从 2025 年的 58.8 亿美元成长到 2034 年的 98.2 亿美元,2026 年至 2034 年的复合年增长率为 5.87%。

随着先进影像技术革新现代医疗流程,全球影像导引治疗系统市场正迅速成长。这些系统能够即时可视化体内结构,使医生能够以更高的精准度进行微创手术。它们广泛应用于肿瘤科、心臟科、神经科和整形外科手术。

CT、MRI、超音波和透视等影像技术的创新正在推动影像引导治疗系统的应用。这些技术帮助医生更精准地进行复杂手术,并降低併发症的风险。医院和专科医疗中心正在加大对先进影像系统的投入,旨在改善手术效果并提高病患安全。

随着微创手术的日益普及,全球影像导引治疗系统市场前景看好。製造商正致力于开发整合多种技术的成像平台,以提供全面的临床资讯。随着医疗保健投资的不断增加和医学影像技术的进步,预计该市场将持续成长。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球影像导引治疗系统市场:依产品划分

  • 市场分析、洞察与预测
  • 电脑断层扫描器(CT)扫描仪
  • 超音波系统
  • 磁振造影(MRI)
  • 内视镜
  • X射线透视仪
  • 正子断层扫描(PET)
  • 单光子发射电脑断层扫描(SPECT)

第五章 全球影像导引治疗系统市场:依连结技术划分

  • 市场分析、洞察与预测
  • 心臟外科手术
  • 神经外科
  • 整形外科手术
  • 泌尿系统
  • 胃肠病学
  • 外科肿瘤学
  • 其他的

第六章:全球影像导引治疗系统市场:依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 研究和学术机构

第七章 全球影像导引治疗系统市场:按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Koninklijke Philips NV
    • Medtronic
    • Siemens Healthineers
    • Analogic Corporation
    • GE Healthcare
    • Varian Medical Systems Inc
    • Brainlab AG
    • Olympus Corporation
    • Stryker
    • Canon Medical Systems Corporation
简介目录
Product Code: VMR112115366

The Image-guided Therapy Systems Market size is expected to reach USD 9.82 Billion in 2034 from USD 5.88 Billion (2025) growing at a CAGR of 5.87% during 2026-2034.

The Global Image-guided Therapy Systems Market is growing rapidly as advanced imaging technologies transform modern medical procedures. Image-guided therapy systems enable physicians to perform minimally invasive procedures with greater accuracy by providing real-time visualization of internal body structures. These systems are widely used in oncology, cardiology, neurology, and orthopedic procedures.

Technological innovations in imaging modalities such as CT, MRI, ultrasound, and fluoroscopy are driving the adoption of image-guided therapy systems. These technologies help physicians perform complex interventions with improved precision and reduced risk of complications. Hospitals and specialized medical centers are increasingly investing in advanced imaging systems to enhance surgical outcomes and improve patient safety.

The future of the Global Image-guided Therapy Systems Market looks promising as minimally invasive procedures continue to gain popularity. Manufacturers are focusing on developing integrated imaging platforms that combine multiple technologies to provide comprehensive clinical insights. With growing healthcare investments and advancements in medical imaging technologies, the market is expected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Computed Tomography (CT) Scanners
  • Ultrasound Systems
  • Magnetic Resonance Imaging (MRI)
  • Endoscope
  • X-ray Fluoroscopy
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)

By Connectivity Technology

  • Cardiac Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • Urology
  • Gastroenterology
  • Oncology Surgery
  • Others

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research & Academic Institutes

COMPANIES PROFILED

  • Koninklijke Philips NV, Medtronic, Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems Inc, Brainlab AG, Olympus Corporation, Stryker, Canon Medical Systems Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Computed Tomography (CT) Scanners Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ultrasound Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Magnetic Resonance Imaging (MRI) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Endoscope Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. X-ray Fluoroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Positron Emission Tomography (PET) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Single Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY CONNECTIVITY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Connectivity Technology
  • 5.2. Cardiac Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Urology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Oncology Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Connectivity Technology
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Connectivity Technology
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Connectivity Technology
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Connectivity Technology
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Connectivity Technology
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMAGE-GUIDED THERAPY SYSTEMS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Koninklijke Philips N.V
    • 9.2.2 Medtronic
    • 9.2.3 Siemens Healthineers
    • 9.2.4 Analogic Corporation
    • 9.2.5 GE Healthcare
    • 9.2.6 Varian Medical Systems Inc
    • 9.2.7 Brainlab AG
    • 9.2.8 Olympus Corporation
    • 9.2.9 Stryker
    • 9.2.10 Canon Medical Systems Corporation